IP Verse

Lipid Nanoparticle Formulation

Patent No. EP3595727 (titled "Lipid Nanoparticle Formulation") was filed by Moderna on Mar 15, 2018. The application was issued on Nov 27, 2024.

Patent Summary

Patent Family

Patent Family

Patent Oppositions

Patent oppositions filed by competitors challenge the validity of a granted patent. These oppositions are typically based on claims of prior art, lack of novelty, or non-obviousness. They are a key part of the process for determining a patent's strength and enforceability.

CompanyOpposition DateRepresentative
PFIZERAug 26, 2025PFIZER

Dossier Documents

The dossier documents provide a comprehensive record of the patent's prosecution history - including filings, correspondence, and decisions made by patent offices - and are crucial for understanding the patent's legal journey and any challenges it may have faced during examination.

  • Date

    Description

  • Get instant alerts for new documents

EP3595727

MODERNA
Application Number
EP18715417A
Filing Date
Mar 15, 2018
Status
Granted And Under Opposition
Oct 25, 2024
Publication Date
Nov 27, 2024
External Links
Slate, Register , Google Patents